Case Study: Unveiling the Urotensin Knot in.
Case Study: Unveiling the Urotensin Knot in Sarah’s Cushing’s Syndrome Sarah, a 42-year-old woman from Lahore, Pakistan, presented with classic symptoms of Cushing’s syndrome –.
Read MoreFeast or Famine? Urotensin II and the.
Feast or Famine? Urotensin II and the Appetite Dysregulation in Hypogonadism Hypogonadism, a condition characterized by insufficient sex hormone production, casts a long shadow on.
Read MoreCase Study: The UII Tango and Mr..
Case Study: The UII Tango and Mr. Khan’s Appetite Blues Patient: Mr. Khan, a 58-year-old male residing in Lahore, Pakistan, presented with a two-year history.
Read MoreUrotensin II – A New Player in.
Urotensin II – A New Player in the Thyroid Storm: Unraveling its Role in Hyperthyroidism Abstract: Thyroid storm, a rare and life-threatening complication of hyperthyroidism,.
Read MoreCase Study: Urotensin II’s Unmasking in a.
Case Study: Urotensin II’s Unmasking in a Thyroid Storm Patient: Sarah, a 35-year-old woman with Graves’ disease diagnosed two years ago. Despite antithyroid medication adherence,.
Read MoreBeyond Diabetes: Urotensin II and the Complexities.
Beyond Diabetes: Urotensin II and the Complexities of Polycystic Ovary Syndrome (PCOS) Polycystic Ovary Syndrome (PCOS) is a multifaceted endocrine disorder affecting approximately 1 in.
Read MoreA Double-Edged Sword: Urotensin II in the.
A Double-Edged Sword: Urotensin II in the Paradox of Addison’s Disease In the labyrinthine realm of human physiology, few conditions present such a captivating paradox.
Read MoreCase Study: Urotensin II and Personalized Medicine.
Case Study: Urotensin II and Personalized Medicine in PCOS Management Patient: Sarah, a 28-year-old woman, presented with symptoms of irregular menstrual cycles, hirsutism, and acne.
Read MoreCase Study: Unveiling the Urotensin II Paradox.
Case Study: Unveiling the Urotensin II Paradox in Sarah’s Addison’s Disease Patient: Sarah, a 35-year-old woman, diagnosed with Addison’s disease two years ago. Presenting Symptoms:.
Read MoreFrom Bench to Bedside: Targeting Urotensin II.
From Bench to Bedside: Targeting Urotensin II for Novel Hyperprolactinemia Therapies Hyperprolactinemia, a condition characterized by elevated prolactin levels in the blood, is a complex.
Read More- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- 227
- 228
- 229
- 230
- 231
- 232
- 233
- 234
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- 248
- 249
- 250
- 251
- 252
- 253
- 254
- 255
- 256
- 257
- 258
- 259
- 260
- 261
- 262
- 263
- 264
- 265
- 266
- 267
- 268
- 269
- 270